Fletcher Reynolds, MD
Orthopaedic Surgery · Fort Myers, FLNPI 1235132465
Payments from drug & device makers
Across 125 payments — averaging $638.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$44K
- Vertex$16K
- Encore Medical, LP$14K
- Johnson & Johnson$2K
- Arthrex$2K
- Zimmer Biomet$1K
- plus $1K from 13 others
What the payments were for
- Royalty or licence$13,81617%
- Consulting fees$3,3004%
- Speaking & faculty fees$54,25868%
- Travel & lodging$2,9754%
- Food & beverage$4,0115%
- Education$1,3202%
- Other$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 56 | $43,826 |
| Vertex | 9 | $15,747 |
| Encore Medical, LP | 11 | $13,816 |
| Johnson & Johnson(2 entities) | 3 | $2,279 |
| Arthrex | 15 | $1,679 |
| Zimmer Biomet | 13 | $1,196 |
| Coastal Medical Technologies LLC | 4 | $202 |
| Globus Medical | 2 | $198 |
| Limacorporate S.p.a. | 1 | $192 |
| Sanara Medtech Inc. | 1 | $174 |
| Lima USA, Inc. | 2 | $153 |
| Stryker | 1 | $95 |
| Baxter Healthcare | 1 | $85 |
| Ortho Development Corporation | 1 | $36 |
| Vericel Corporation | 1 | $25 |
| Orthogenrx Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Medline Industries LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$55,265
- Zynrelef$43,128
- JOURNAVX$15,631
- APONVIE$6,833
- DERMABOND$2,250
- STRATAFIX$2,250
- SURGICEL NU-KNIT$2,250
- SURGIFLO Hemostatic Matrix$2,250
- Oxford$636
- Product Portfolio$192
- CellerateRx$174
- Genflex2 Total Knee System$123
- Sports Medicine Product Portfolio$112
How this compares
$79,765 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 86 | $2,260 |
| Duloxetine Hcl | 52 | $476 |
| Amoxicillin | 65 | $140 |
| Meloxicam | 37 | $109 |
| Gabapentin | 20 | $105 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fort Myers
- William HodgeFort Myers$1.1M
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$35M
- Mark FrankleTemple Terrace$31.4M
- David WatsonTemple Terrace$21M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Martin RocheFt. Lauderdale$7.3M
- Robert SantrockFernandina Beach$7.3M
- Steven LyonsTampa$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.